- Home
- CRNX vs ABR Comparison
CRNX vs ABR Comparison
Compare CRNX & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- ABR
- Stock Information
- Founded
- CRNX 2008
- ABR 2003
- Country
- CRNX United States
- ABR United States
- Employees
- CRNX N/A
- ABR N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- ABR Real Estate Investment Trusts
- Sector
- CRNX Health Care
- ABR Real Estate
- Exchange
- CRNX Nasdaq
- ABR Nasdaq
- Market Cap
- CRNX 2.8B
- ABR 2.3B
- IPO Year
- CRNX 2018
- ABR 2004
- Fundamental
- Price
- CRNX $42.65
- ABR $12.09
- Analyst Decision
- CRNX Buy
- ABR Hold
- Analyst Count
- CRNX 12
- ABR 5
- Target Price
- CRNX $74.45
- ABR $12.00
- AVG Volume (30 Days)
- CRNX 1.9M
- ABR 2.3M
- Earning Date
- CRNX 11-11-2025
- ABR 10-31-2025
- Dividend Yield
- CRNX N/A
- ABR 9.93%
- EPS Growth
- CRNX N/A
- ABR N/A
- EPS
- CRNX N/A
- ABR 0.91
- Revenue
- CRNX $1,392,000.00
- ABR $600,587,000.00
- Revenue This Year
- CRNX $469.59
- ABR N/A
- Revenue Next Year
- CRNX $705.27
- ABR $5.24
- P/E Ratio
- CRNX N/A
- ABR $13.35
- Revenue Growth
- CRNX 0.51
- ABR N/A
- 52 Week Low
- CRNX $24.10
- ABR $8.43
- 52 Week High
- CRNX $62.53
- ABR $15.76
- Technical
- Relative Strength Index (RSI)
- CRNX 65.23
- ABR 52.99
- Support Level
- CRNX $40.33
- ABR $11.93
- Resistance Level
- CRNX $47.41
- ABR $12.58
- Average True Range (ATR)
- CRNX 2.24
- ABR 0.21
- MACD
- CRNX 0.31
- ABR 0.03
- Stochastic Oscillator
- CRNX 65.12
- ABR 48.74
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.